 BEIJING--BUSINESS WIRE--Genetron Holdings Limited Genetron Health or the Company, NASDAQ:GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that it will report unaudited financial results for the fourth quarter and full year ended December 31, 2020 on March 25, 2021 before the US market open. Management will host a conference call for in 